HLUBF:OTCMKTS
H Lundbeck A/S Class A
$6.85
0.00%
(0.00) 1D
Oct 8, 1:38:30 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUBF...
Mkt. cap
54.49B
Avg. vol.
108.00
Volume
1.00
52-wk high
$6.85
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
Mkt. cap
54.49B
Avg. vol.
108.00
Volume
1.00
52-wk high
$6.85
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
News stories
From web sources and news partners
marketscreener.com
·
27 minutes ago
Nasdaq rebounds but remains on track for fourth straight weekly decline
The Motley Fool
·
32 minutes ago
After the Midterm Rally, the Dow Is on Track to Beat the Nasdaq for the First Time Since 2022. Here's What History Says Could Come Next.
FXEmpire
·
1 hour ago
Nasdaq and S&P 500: Tech Stocks Rebound as Data-Center Risks Cap Gains
Traders Union
·
4 hours ago
S&P 500 technical analysis: Oversold CCI and Stoch RSI hint at rebound potential
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5K
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitelundbeck.com